The Safety of Soft Contact Lenses in Children

Mark A Bullimore1

  • 1*MCOptom, PhD, FAAO University of Houston College of Optometry (MAB), Houston, Texas.

Insights

Soft contact lens wear in children shows low rates of complications. Corneal infiltrative events are comparable to adults, and microbial keratitis is rare in pediatric soft contact lens wearers.

Area of Science:

  • Ophthalmology
  • Pediatric Optometry
  • Contact Lens Research

Background:

  • Increasing interest in fitting children with soft contact lenses.
  • Need to assess safety and complication rates in pediatric populations.
  • Soft contact lenses offer vision correction for a growing pediatric demographic.

Purpose of the Study:

  • To collate data on the incidence of soft contact lens complications in children under 18.
  • Specifically review rates of corneal infiltrative events and microbial keratitis.
  • Evaluate the safety of soft contact lens wear in pediatric patients.

Main Methods:

  • Systematic review of peer-reviewed papers from PubMed and Web of Science.
  • Inclusion of epidemiological studies, case series, and prospective/retrospective studies.
  • Analysis of safety outcomes from studies representing significant patient years of wear.

Main Results:

  • Nine prospective studies (1800 patient years) in 7-19 year olds reported safety outcomes.
  • Corneal infiltrative events ranged from 97 to 335 per 10,000 years across age groups.
  • No cases of microbial keratitis were reported in prospective studies; retrospective data showed low incidence in older children.

Conclusions:

  • Incidence of corneal infiltrative events in children is comparable to adults.
  • Pediatric soft contact lens wear demonstrates a favorable safety profile.
  • Younger children (8-11 years) may experience even lower rates of complications.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
387
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
341
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
445
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
103